China Strikes Back After Trump Imposes 10% Tariff on Goods

It will take months but drug prices will increase,

Caplan said

Thus the effects of any policy changes may take a while to trickle through the supply chain,

she said

When generic drugs are sold through distributors and through the supply chain, there’s usually a contract,

he said

Better resourced hospitals and pharmacies have enough money or wherewithal to call their wholesaler to see if they can buy more of certain types of products,

she said

From the base ingredients to the finished products, U.S. medicines rely on a global supply chain that is already stressed and in need of strengthening,

he said

So if any manufacturer wants to go ahead and increase their prices, they’re going to pay a different tax on the other end if they do so,

she said

Generic manufacturers simply can't absorb new costs,

Murphy said on Sunday

The United States needs to view and solve its own fentanyl issue in an objective and rational way ... (China is) one of the world's toughest countries on counternarcotics both in terms of policy and its implementation."

the Foreign Ministry said, continuing

We are nowhere close to robust indictments, robust prosecutions in either the money laundering sector or smuggling of precursors to the Mexican cartels,

she said in a podcast

Obtaining support from Beijing to stop the flow of illicit fentanyl and its precursor chemicals is an important first step in addressing the supply problem,

Liu wrote

The global fentanyl supply chain, which ends with the deaths of Americans, often starts with chemical companies in China,

the then US attorney general Merrick Garland said last year

With countries with whom China has good relations or with whom it wants to build good relations ... it extends law enforcement and counter-narcotics cooperation,

she explained

International drug cartels are increasingly turning to specialized Chinese criminal gangs for swift, cheap and secure money laundering services,

wrote Zongyuan Zoe Liu in a September report for the Council on Foreign Relations

The U.S. will likely see 'new and worsened shortages of important medications,' and those costs will be 'passed down to payers and patients, including those in the Medicare and Medicaid programs,'

the Healthcare Distribution Alliance said